KAKKIS EMIL D
Insider CIK 1248093 · RARE President & CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2026-04-16 | 2026-04-20 | 132,693 | — | $0 | 132,693 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-04-16 | 2026-04-20 | 76,745 | — | $0 | 735,739 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-02 | 2026-03-03 | 54,404 | $22.80 | $1.24M | 658,994 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-03-01 | 2026-03-03 | 71,177 | — | $0 | 712,908 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-03-03 | 2025-03-04 | 73,434 | $42.10 | $3.09M | 641,731 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2025-03-01 | 2025-03-04 | 78,448 | — | $0 | 78,448 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 43,268 | — | $0 | 607,873 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 107,292 | — | $0 | 715,165 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-02-28 | 2025-03-04 | 25,000 | $42.48 | $1.06M | 2,158,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-12-30 | 2024-12-31 | 11,727 | $42.23 | $495.2K | 2,183,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-12-10 | 2024-12-11 | 8,273 | $50.00 | $413.6K | 2,195,712 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | G Gift | 2024-12-09 | 2024-12-11 | 20,000 | — | $0 | 2,203,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-09-03 | 2024-09-05 | 20,000 | $55.85 | $1.12M | 2,223,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-08-06 | 2024-08-07 | 20,000 | $50.17 | $1.00M | 2,243,985 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 70,094 | — | $0 | 70,094 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 3,132 | — | $0 | 563,913 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2024-03-01 | 2024-03-05 | 17,417 | $53.69 | $935.1K | 560,781 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 38,428 | — | $0 | 578,198 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-02-07 | 2024-02-08 | 30,000 | $45.00 | $1.35M | 539,770 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-12-29 | 2024-01-02 | 30,000 | $47.87 | $1.44M | 569,770 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2023-10-19 | 2023-10-23 | 47,853 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-10-19 | 2023-10-23 | 47,853 | $33.52 | $1.60M | 599,743 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2023-10-19 | 2023-10-23 | 47,853 | $6.86 | $328.3K | 647,029 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-03-01 | 2023-03-03 | 83,500 | — | $0 | 83,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 8,716 | — | $0 | 569,406 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2023-03-01 | 2023-03-03 | 16,140 | $45.65 | $736.8K | 599,176 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 46,200 | — | $0 | 615,606 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-12-30 | 2023-01-03 | 19,582 | $45.57 | $892.4K | 541,108 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-03-01 | 2022-03-03 | 92,360 | — | $0 | 92,360 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-03-01 | 2022-03-03 | 52,041 | — | $0 | 634,226 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2022-03-01 | 2022-03-03 | 12,162 | $67.37 | $819.4K | 582,185 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2021-10-14 | 2021-10-18 | 853 | $81.00 | $69.1K | 594,347 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2021-05-06 | 2021-05-10 | 852 | $115.71 | $98.6K | 595,200 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-05-03 | 2021-05-05 | 30,000 | $107.80 | $3.23M | 2,259,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-03-01 | 2021-03-03 | 36,000 | — | $0 | 36,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-03-01 | 2021-03-03 | 30,000 | $141.80 | $4.25M | 2,289,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 18,000 | — | $0 | 596,941 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 15,453 | — | $0 | 612,394 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2021-03-01 | 2021-03-03 | 16,342 | $142.47 | $2.33M | 596,052 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-01-04 | 2021-01-05 | 30,000 | $136.90 | $4.11M | 2,329,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-11-02 | 2020-11-04 | 30,000 | $96.82 | $2.90M | 2,359,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-10-14 | 2020-10-16 | 852 | $92.69 | $79.0K | 610,189 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-09-01 | 2020-09-02 | 30,000 | $82.63 | $2.48M | 2,389,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-07-13 | 2020-07-15 | 40,000 | $85.35 | $3.41M | 2,419,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-06-01 | 2020-06-03 | 1,334 | $69.38 | $92.6K | 611,041 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-05-06 | 2020-05-08 | 852 | $66.26 | $56.5K | 652,797 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-04-19 | 2020-04-21 | 851 | $58.57 | $49.8K | 653,649 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | X Exercise deriv | 2020-03-12 | 2020-03-13 | 83,167 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | X Exercise deriv | 2020-03-12 | 2020-03-13 | 66,533 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | X Exercise | 2020-03-12 | 2020-03-13 | 83,167 | $3.01 | $250.3K | 587,967 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | X Exercise | 2020-03-12 | 2020-03-13 | 66,533 | $3.01 | $200.3K | 654,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-03-01 | 2020-03-03 | 56,100 | — | $0 | 56,100 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 18,782 | — | $0 | 511,696 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-03-01 | 2020-03-03 | 6,896 | $56.08 | $386.7K | 504,800 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 17,000 | — | $0 | 492,914 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-10-14 | 2019-10-16 | 3,435 | — | $0 | 475,914 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | P Buy | 2019-09-11 | 2019-09-11 | 5,000 | $43.63 | $218.2K | 472,479 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-06-01 | 2019-06-04 | 1,327 | $54.93 | $72.9K | 467,479 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-05-21 | 2019-05-22 | 1,414 | $59.50 | $84.1K | 468,806 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-05-06 | 2019-05-07 | 3,435 | — | $0 | 470,220 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-04-19 | 2019-04-23 | 798 | $64.43 | $51.4K | 466,785 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-03-05 | 2019-04-17 | 2,890 | $65.52 | $189.4K | 467,583 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-04-17 | 66,000 | — | $0 | 66,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-04-17 | 20,000 | — | $0 | 470,473 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-03-04 | 66,000 | — | $0 | 66,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-03-01 | 2019-03-04 | 2,802 | $67.55 | $189.3K | 467,670 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-03-04 | 20,000 | — | $0 | 470,472 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-06-01 | 2018-06-04 | 926 | $73.73 | $68.3K | 450,472 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-05-21 | 2018-05-22 | 986 | $64.79 | $63.9K | 451,398 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-04-19 | 2018-04-19 | 3,429 | — | $0 | 452,384 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-03-01 | 2018-03-05 | 94,500 | — | $0 | 94,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-03-01 | 2018-03-05 | 1,114 | $48.43 | $54.0K | 448,955 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-03-01 | 2018-03-05 | 19,500 | — | $0 | 450,069 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | P Buy | 2017-08-28 | 2017-08-29 | 1,647 | $52.96 | $87.2K | 2,559,741 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | P Buy | 2017-08-28 | 2017-08-29 | 5,853 | $52.40 | $306.7K | 2,558,094 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-06-01 | 2017-06-01 | 1,006 | $56.61 | $56.9K | 430,569 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-05-21 | 2017-05-22 | 1,072 | $57.47 | $61.6K | 431,575 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-03-01 | 2017-03-01 | 78,000 | — | $0 | 78,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-03-01 | 2017-03-01 | 13,000 | — | $0 | 432,647 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-15 | 2016-11-17 | 4,180 | $82.36 | $344.3K | 447,347 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-15 | 2016-11-17 | 1,414 | $79.39 | $112.3K | 465,733 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-15 | 2016-11-17 | 6,451 | $80.64 | $520.2K | 459,282 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-15 | 2016-11-17 | 200 | $83.01 | $16.6K | 447,147 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-11-15 | 2016-11-17 | 7,755 | $81.55 | $632.4K | 451,527 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-10-14 | 2016-10-18 | 2,345 | $64.41 | $151.0K | 468,947 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-10-14 | 2016-10-18 | 1,800 | $64.78 | $116.6K | 467,147 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-10-14 | 2016-10-18 | 6,515 | $61.97 | $403.7K | 480,632 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-10-14 | 2016-10-18 | 9,340 | $63.06 | $589.0K | 471,292 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-08-15 | 2016-08-17 | 13,903 | $67.39 | $936.9K | 493,244 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-08-15 | 2016-08-17 | 6,097 | $68.12 | $415.3K | 487,147 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-07-15 | 2016-07-19 | 6,450 | $51.34 | $331.1K | 507,147 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-07-15 | 2016-07-19 | 13,550 | $50.61 | $685.8K | 513,597 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-01 | 2016-06-03 | 63,700 | — | $0 | 63,700 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-01 | 2016-06-03 | 10,700 | — | $0 | 527,147 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-05-21 | 2016-05-24 | 1,072 | $64.01 | $68.6K | 516,447 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-05-16 | 2016-05-18 | 6,390 | $60.32 | $385.4K | 520,314 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-05-16 | 2016-05-18 | 10,815 | $59.37 | $642.1K | 526,704 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-05-16 | 2016-05-18 | 200 | $61.93 | $12.4K | 517,519 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-05-16 | 2016-05-18 | 2,595 | $61.34 | $159.2K | 517,719 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-04-15 | 2016-04-19 | 9,834 | $70.35 | $691.8K | 542,895 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-04-15 | 2016-04-19 | 4,790 | $69.46 | $332.7K | 552,729 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2016-04-15 | 2016-04-19 | 5,376 | $71.06 | $382.0K | 537,519 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-31 | 2016-01-04 | 605 | $114.61 | $69.3K | 575,640 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-31 | 2016-01-04 | 2,191 | $112.91 | $247.4K | 578,947 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-31 | 2016-01-04 | 2,702 | $113.83 | $307.6K | 576,245 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-30 | 2016-01-04 | 5,465 | $114.61 | $626.3K | 587,338 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-30 | 2016-01-04 | 3,600 | $115.56 | $416.0K | 583,738 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-30 | 2016-01-04 | 2,600 | $116.31 | $302.4K | 581,138 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-12-30 | 2016-01-04 | 2,837 | $113.30 | $321.4K | 592,803 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-11-30 | 2015-12-02 | 11,374 | $98.62 | $1.12M | 597,055 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-11-30 | 2015-12-02 | 1,950 | $96.46 | $188.1K | 613,690 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-11-30 | 2015-12-02 | 5,261 | $97.88 | $514.9K | 608,429 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-11-30 | 2015-12-02 | 1,415 | $99.42 | $140.7K | 595,640 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-10-30 | 2015-11-03 | 4,400 | $100.43 | $441.9K | 617,540 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-10-30 | 2015-11-03 | 1,900 | $101.20 | $192.3K | 615,640 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-10-30 | 2015-11-03 | 7,600 | $99.42 | $755.6K | 621,940 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-10-30 | 2015-11-03 | 6,100 | $98.63 | $601.6K | 629,540 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-05-21 | 2015-05-27 | 68,300 | — | $0 | 68,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2015-05-21 | 2015-05-27 | 11,400 | — | $0 | 635,640 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 130,344 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | C Conversion deriv | 2014-02-05 | 2014-02-07 | 1,956,686 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 24,950 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 78 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 83,039 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 260,688 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-02-07 | 41,583 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-03-28 | 260,688 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | J Other deriv | 2014-02-05 | 2014-03-28 | 83,167 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | C Conversion | 2014-02-05 | 2014-02-07 | 624,240 | — | $0 | 624,240 | SEC↗ |